tradingkey.logo

GE Healthcare Technologies Inc

GEHC
74.950USD
-0.050-0.07%
Cierre 10/31, 16:00ETCotizaciones retrasadas 15 min
34.14BCap. mercado
15.40P/E TTM

GE Healthcare Technologies Inc

74.950
-0.050-0.07%

Más Datos de GE Healthcare Technologies Inc Compañía

GE HealthCare Technologies Inc. is a healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first artificial intelligence (AI)-enabled solutions, services and data analytics. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.

Información de GE Healthcare Technologies Inc

Símbolo de cotizaciónGEHC
Nombre de la empresaGE Healthcare Technologies Inc
Fecha de salida a bolsaDec 15, 2022
Director ejecutivoMr. Kevin Michael O'Neill
Número de empleados53000
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 15
Dirección500 West Monroe Street
CiudadCHICAGO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal60661
Teléfono18337351139
Sitio Webhttps://www.gehealthcare.com
Símbolo de cotizaciónGEHC
Fecha de salida a bolsaDec 15, 2022
Director ejecutivoMr. Kevin Michael O'Neill

Ejecutivos de GE Healthcare Technologies Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.81K
-4.01%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
64.93K
-1.69%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.13%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
13.61K
+55.32%
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
10.16K
+43.77%
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
9.12K
+51.33%
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
271.81K
-4.01%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
64.93K
-1.69%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
41.00K
-2.13%
Ms. Jeannette Bankes
Ms. Jeannette Bankes
Chief Executive Officer - Patient Care Solutions
Chief Executive Officer - Patient Care Solutions
37.03K
--
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
14.33K
+55.74%
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
13.61K
+55.32%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Total Imaging
2.20B
44.02%
Total Ultrasound
1.29B
25.74%
Total PCS
778.00M
15.54%
Total PDx
729.00M
14.56%
Other
6.00M
0.12%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Total Imaging
2.20B
44.02%
Total Ultrasound
1.29B
25.74%
Total PCS
778.00M
15.54%
Total PDx
729.00M
14.56%
Other
6.00M
0.12%

Estadísticas de accionistas

Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.39%
BlackRock Institutional Trust Company, N.A.
5.41%
Dodge & Cox
5.17%
Capital Research Global Investors
4.38%
State Street Investment Management (US)
4.32%
Otro
69.32%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.39%
BlackRock Institutional Trust Company, N.A.
5.41%
Dodge & Cox
5.17%
Capital Research Global Investors
4.38%
State Street Investment Management (US)
4.32%
Otro
69.32%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
44.31%
Investment Advisor/Hedge Fund
26.99%
Hedge Fund
7.59%
Research Firm
3.54%
Pension Fund
2.52%
Sovereign Wealth Fund
1.46%
Bank and Trust
1.37%
Insurance Company
0.66%
Individual Investor
0.28%
Otro
11.28%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
2385
403.33M
88.54%
+7.41M
2025Q2
2403
369.63M
80.96%
-58.15M
2025Q1
2446
400.73M
87.52%
-35.60M
2024Q4
2344
405.16M
88.60%
-9.34M
2024Q3
2188
396.50M
86.79%
-11.03M
2024Q2
2081
391.61M
85.76%
-10.20M
2024Q1
2000
385.11M
84.39%
-2.29M
2023Q4
1855
385.99M
84.77%
-4.81M
2023Q3
1708
381.18M
83.73%
+1.51M
2023Q2
1574
374.50M
82.34%
-3.85M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
51.90M
11.37%
+696.51K
+1.36%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
24.63M
5.39%
-631.11K
-2.50%
Jun 30, 2025
Dodge & Cox
23.57M
5.16%
+6.98M
+42.10%
Jun 30, 2025
Capital Research Global Investors
19.97M
4.38%
-1.99M
-9.05%
Jun 30, 2025
State Street Investment Management (US)
19.66M
4.31%
+372.75K
+1.93%
Jun 30, 2025
Geode Capital Management, L.L.C.
11.94M
2.62%
+231.30K
+1.97%
Jun 30, 2025
Harris Associates L.P.
9.67M
2.12%
+4.04M
+71.68%
Jun 30, 2025
Invesco Capital Management (QQQ Trust)
9.37M
2.05%
-33.12K
-0.35%
Aug 31, 2025
Citadel Advisors LLC
9.30M
2.04%
+2.38M
+34.46%
Jun 30, 2025
Hotchkis and Wiley Capital Management, LLC
7.20M
1.58%
+1.45M
+25.17%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: lun., 6 de oct
Actualizado: lun., 6 de oct
Nombre
Proporción
Invesco S&P Spin-Off ETF
7.62%
Langar Global HealthTech ETF
5.67%
Global X HealthTech ETF
3.98%
iShares U.S. Medical Devices ETF
3.87%
Absolute Select Value ETF
2.88%
VanEck Morningstar Wide Moat Value ETF
2.43%
Otter Creek Focus Strategy ETF
2.38%
Knowledge Leaders Developed World ETF
2.25%
VanEck Morningstar Wide Moat ETF
2.18%
First Trust Indxx Medical Devices ETF
2.15%
Ver más
Invesco S&P Spin-Off ETF
Proporción7.62%
Langar Global HealthTech ETF
Proporción5.67%
Global X HealthTech ETF
Proporción3.98%
iShares U.S. Medical Devices ETF
Proporción3.87%
Absolute Select Value ETF
Proporción2.88%
VanEck Morningstar Wide Moat Value ETF
Proporción2.43%
Otter Creek Focus Strategy ETF
Proporción2.38%
Knowledge Leaders Developed World ETF
Proporción2.25%
VanEck Morningstar Wide Moat ETF
Proporción2.18%
First Trust Indxx Medical Devices ETF
Proporción2.15%

Dividendos

Un total de 96.00M USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
Apr 25, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Jun 15, 2023 going ex on May 22, 2023
May 23, 2023
Jun 15, 2023
May 22, 2023

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI